This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cardiome Pharma Corp (CRME)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 17.66M 12.71M 10.98M 41.27M
Receivables 6.81M 9.50M 6.67M 978.00K
Inventories 4.40M 5.33M 6.60M 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 32.95M 32.01M 28.33M 43.02M
Property, Plant & Equipment, Gross 1.70M 1.57M 1.23M 782.00K
Accumulated Depreciation & Depletion 961.00K 758.00K 615.00K 511.00K
Property, Plant & Equipment, Net 740.00K 811.00K 618.00K 271.00K
Intangibles 14.22M 16.16M 18.07M 1.51M
Other Non-Current Assets 402.00K 821.00K 0.00 0.00
Total Non-Current Assets 15.68M 18.11M 19.00M 1.78M
Liabilities & Shareholder Equity
Total Assets 48.63M 50.12M 47.33M 44.79M
Accounts Payable 3.47M 5.47M 6.45M 1.04M
Short Term Debt 4.00M 1.71M 0.00 32.50M
Other Current Liabilities 2.62M 0.00 0.00 0.00
Total Current Liabilities 17.30M 18.15M 17.69M 36.93M
Long Term Debt 6.00M 10.29M 0.00 0.00
Deferred Income Taxes 2.48M 4.54M 7.00M 0.00
Other Non-Current Liabilities 2.92M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 11.40M 14.83M 7.00M 0.00
Total Liabilities 28.69M 32.98M 24.69M 36.93M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 19.94M 17.14M 22.64M 7.86M
Common Par n.a. 0.00 0.00 0.00
Additional Paid In Capital 346.70M 318.99M 305.43M 295.19M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings -343.44M -318.97M -300.75M -305.52M
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 16.67M 17.12M 17.96M 18.18M
Total Capitalization 25.94M 27.43M 22.64M 7.86M
Total Equity 19.94M 17.14M 22.64M 7.86M
Total Liabilities & Stock Equity 48.63M 50.12M 47.33M 44.79M
Total Common Shares Outstanding 20.15M 16.59M 14.96M 12.47M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 18.20M 16.23M 12.77M 12.25M
Diluted Weighted Shares Outstanding 18.20M 16.23M 12.93M 12.25M
Number of Employees NA 85 75 13
Number of Part-Time Employees NA 0 0 0
CRME News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

CRME Cardiome Pharma Corp

Chart of CRME

Analysts Ratings for CRME

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CRME ANALYST REPORT

CRME Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs